Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
Open Access
- 20 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 130 (18) , 2163-2169
Abstract
Background: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the role of macrophage Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. Methods: C57BL/6 mice were injected with a 50% glycerin solution at bilateral back limbs to induce rhabdomyolysis, and CLI-095 or pyrrolidine dithiocarbamate (PDTC) was intraperitoneally injected at 0.5 h before molding. Serum creatinine levels, creatine kinase, the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6, and hematoxylin and eosin stainings of kidney tissues were tested. The infiltration of macrophage, mRNA levels, and protein expression of TLR4 and NF-κB were investigated by immunofluorescence double-staining techniques, reverse transcriptase-quantitative polymerase chain reaction, and Western blotting, respectively. In vitro, macrophage RAW264.7 was stimulated by ferrous myoglobin; the cytokines, TLR4 and NF-κB expressions were also detected. Results: In an in vivo study, using CLI-095 or PDTC to block TLR4/NF-κB, functional and histologic results showed that the inhibition of TLR4 or NF-κB alleviated glycerol-induced renal damages (P < 0.01). CLI-095 or PDTC administration suppressed proinflammatory cytokine (TNF-α, IL-6, and IL-1β) production and macrophage infiltration into the kidney (P < 0.01). Moreover, in an in vitro study, CLI-095 or PDTC suppressed myoglobin-induced expression of TLR4, NF-κB, and proinflammatory cytokine levels in macrophage RAW264.7 cells (P < 0.01). Conclusion: The pharmacological inhibition of TLR4/NF-κB exhibited protective effects on rhabdomyolysis-induced AKI by the regulation of proinflammatory cytokine production and macrophage infiltration.Keywords
This publication has 27 references indexed in Scilit:
- Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- The synthetic polyphenoltert-butyl-bisphenol inhibits myoglobin-induced dysfunction in cultured kidney epithelial cellsFree Radical Research, 2010
- Pentobarbital Reduces Rhabdomyolysis-Induced Acute Renal Failure in Conscious RatsJournal of Trauma: Injury, Infection & Critical Care, 2009
- Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other DiseasesPharmaceutical Research, 2008
- TLR4 activation mediates kidney ischemia/reperfusion injuryJournal of Clinical Investigation, 2007
- Toll-Like Receptor 4 Ligation on Intrinsic Renal Cells Contributes to the Induction of Antibody-Mediated Glomerulonephritis via CXCL1 and CXCL2Journal of the American Society of Nephrology, 2007
- Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory responseAmerican Journal of Physiology-Renal Physiology, 2006
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- Inferences, questions and possibilities in Toll-like receptor signallingNature, 2004
- Rhabdomyolysis: A reviewMuscle & Nerve, 2002